Immunic, Inc. has implemented corporate stock split actions on public exchanges, most notably executing a one-for-ten reverse stock split on April 27, 2026. This strategic adjustment consolidated every ten existing shares of common stock into one newly minted share, effectively raising the nominal per-share trading value. The primary motivation behind executing this corporate restructuring was to safeguard the company's continuous listing status on the Nasdaq exchange by satisfying minimum price compliance rules, insulating the equity from delisting risks while supporting ongoing capital-raising initiatives.